SJ Medical
The global Distal Protection Filter (DPF) market is undergoing a significant transformation, driven by the increasing prevalence of cardiovascular diseases and the rapid adoption of minimally invasive surgeries. As an essential component in carotid artery stenting (CAS) and saphenous vein graft (SVG) interventions, these devices are critical in preventing distal embolization—a primary cause of stroke and myocardial infarction during interventional procedures.
In the current industrial context, North America and Europe remain dominant markets due to advanced healthcare infrastructure; however, the Asia-Pacific region, led by China's high-tech manufacturing, is emerging as a global hub for both consumption and production. Global procurement managers are increasingly looking towards specialized Chinese factories that offer a balance of high-end Nitinol material technology, strict quality compliance (ISO 13485), and cost-effective manufacturing scales.
The market for embolic protection devices is projected to grow at a CAGR of over 7% through 2030, reflecting the global shift toward percutaneous therapies.
Modern DPFs require micron-level laser cutting and advanced membrane coating to ensure optimal pore size for blood flow while capturing debris.
Procurement is shifting from traditional Western brands to qualified Chinese OEMs who provide comparable clinical outcomes with better lead times.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
The next decade of distal protection technology will be defined by miniaturization and biocompatibility. As a leading supplier, we are closely monitoring and implementing these industry trends:
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
Equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities, we ensure high levels of manufacturing accuracy.
In neurovascular procedures, our distal filters provide a safety net during stenting, capturing plaque that could otherwise lead to ischemic stroke.
Used specifically in degenerated saphenous vein grafts where the risk of distal embolization is significantly higher than in native arteries.
Supporting lower limb revascularization, ensuring that calcified debris doesn't clog smaller distal vessels during angioplasty.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
Our global footprint is expanding rapidly. We have established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Our products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We provide comprehensive professional services from pre-sales consultation to responsive after-sales support.